G2 checkpoint targeting via Wee1 inhibition radiosensitizes EGFRvIII-positive glioblastoma cellsMeryem Cetin(Universität Hamburg), Nina Struve(Universität Hamburg)Radiation OncologyJanuary 29, 202310.1186/s13014-023-02210-xCited by 11SaveCiteExport RISWatch citationsRelated PapersEGFRvIII upregulates DNA mismatch repair resulting in increased temozolomide sensitivity of MGMT promoter methylated glioblastoma|Oncogene|2020|67